Partnerships in the biotechnology and pharmaceutical industries can provide the necessary means for achieving success. This talk will discuss typical partnership mechanisms, technology and product licensing and the concept of strategic investing. The importance of specific partnerships in Lundbeck's development as a USA "specialty pharma" company will be discussed in detail. This talk will conclude with the speaker's predictions regarding the future of pharma/biotech partnerships and the evolution of the "specialty pharma" industry.
Back to Strategies for Growth: How a “Small” Company can become a “Big” Player
Back to The 37th Middle Atlantic Regional Meeting (May 22-25, 2005)